These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 8720589)

  • 21. [Effects of rosuvastatin on monocrotaline-induced pulmonary artery hypertension in rats].
    Li XL; Guan RJ; Xu QH; Wu ZY
    Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Mar; 39(3):247-53. PubMed ID: 21609531
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effect of tetrandrine on pulmonary hypertension induced by monocrotaline in rats].
    Zhang S; Sun B; Zhang J; Li F; Lei S; Cheng D; Yang X; Tan Y; Yao X; Li T
    Hua Xi Yi Ke Da Xue Xue Bao; 1995 Dec; 26(4):378-80. PubMed ID: 8732055
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PRX-08066, a novel 5-hydroxytryptamine receptor 2B antagonist, reduces monocrotaline-induced pulmonary arterial hypertension and right ventricular hypertrophy in rats.
    Porvasnik SL; Germain S; Embury J; Gannon KS; Jacques V; Murray J; Byrne BJ; Shacham S; Al-Mousily F
    J Pharmacol Exp Ther; 2010 Aug; 334(2):364-72. PubMed ID: 20430844
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differences in the acute pulmonary vascular effects of oxygen with nitric oxide and diltiazem: implications for the long-term treatment of pulmonary arterial hypertension.
    Day RW
    Congenit Heart Dis; 2013; 8(1):71-7. PubMed ID: 22891699
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Preventive effects of tetrandrine on pulmonary hypertension and right ventricular hypertrophy in rats induced by monocrotaline].
    Jin X; Zhang X; Xing J; Liu K; Wang H
    Zhongguo Zhong Yao Za Zhi; 1996 Dec; 21(12):751-2, 763. PubMed ID: 9812685
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel Ca2+ channel antagonist reverses cardiac hypertrophy and pulmonary arteriolar remodeling in experimental pulmonary hypertension.
    Pereira SL; Kummerle AE; Fraga CA; Barreiro EJ; Rocha Nde N; Ferraz EB; do Nascimento JH; Sudo RT; Zapata-Sudo G
    Eur J Pharmacol; 2013 Feb; 702(1-3):316-22. PubMed ID: 23399770
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aspirin attenuates pulmonary arterial hypertension in rats by reducing plasma 5-hydroxytryptamine levels.
    Shen L; Shen J; Pu J; He B
    Cell Biochem Biophys; 2011 Sep; 61(1):23-31. PubMed ID: 21327581
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Calcium antagonistic and binding properties of semotiadil (SD-3211), a benzothiazine derivative assessed in cerebral and coronary arteries.
    Nakayama K; Morimoto K; Nozawa Y; Tanaka Y
    J Cardiovasc Pharmacol; 1992 Sep; 20(3):380-91. PubMed ID: 1279282
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effect of simvastatin on rat pulmonary hypertension induced by high pulmonary blood flow and injected monocrotaline].
    Zhao L; Zhou TF; Liu HM; Li M; Dou H; Tang ZH
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Jun; 38(3):463-5, 479. PubMed ID: 17593832
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Beneficial effects of aqueous extract of stem bark of Terminalia arjuna (Roxb.), An ayurvedic drug in experimental pulmonary hypertension.
    Meghwani H; Prabhakar P; Mohammed SA; Seth S; Hote MP; Banerjee SK; Arava S; Ray R; Maulik SK
    J Ethnopharmacol; 2017 Feb; 197():184-194. PubMed ID: 27401289
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pioglitazone alleviates cardiac and vascular remodelling and improves survival in monocrotaline induced pulmonary arterial hypertension.
    Behringer A; Trappiel M; Berghausen EM; Ten Freyhaus H; Wellnhofer E; Odenthal M; Blaschke F; Er F; Gassanov N; Rosenkranz S; Baldus S; Kappert K; Caglayan E
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Apr; 389(4):369-79. PubMed ID: 26742933
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modafinil improves monocrotaline-induced pulmonary hypertension rat model.
    Lee H; Kim KC; Cho MS; Suh SH; Hong YM
    Pediatr Res; 2016 Jul; 80(1):119-27. PubMed ID: 26959484
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The effect and mechanism of felodipine on monocrotaline induced pulmonary hypertension in rats].
    Zeng Z; Huang H; Li X
    Zhonghua Jie He He Hu Xi Za Zhi; 2002 Aug; 25(8):461-4. PubMed ID: 12425830
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [TRPC6 mediates the enhancements of pulmonary arterial tone and intracellular Ca2+ concentration of pulmonary arterial smooth muscle cells in pulmonary hypertension rats].
    Zhang MF; Liu XR; Yang N; Lin MJ
    Sheng Li Xue Bao; 2010 Feb; 62(1):55-62. PubMed ID: 20179889
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of rho kinase attenuates high flow induced pulmonary hypertension in rats.
    Li FH; Xia W; Li AW; Zhao CF; Sun RP
    Chin Med J (Engl); 2007 Jan; 120(1):22-9. PubMed ID: 17254483
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effects of prostaglandin E1 (PGE1) on pulmonary hypertension and lung vascular remodeling in a rat monocrotaline model of human pulmonary hypertension].
    Ono S; Tanita T; Hoshikawa Y; Song C; Maeda S; Tabata T; Noda M; Ueda S; Ashino Y; Fujimura S
    Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Aug; 33(8):862-7. PubMed ID: 7474567
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Myocardial and anti-inflammatory effects of chronic bosentan therapy in monocrotaline-induced pulmonary hypertension.
    Fontoura D; Oliveira-Pinto J; Tavares-Silva M; Leite S; Vasques-Nóvoa F; Mendes-Ferreira P; Lourenço AP; Leite-Moreira AF
    Rev Port Cardiol; 2014 Apr; 33(4):213-22. PubMed ID: 24780128
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiplatelet activity of semotiadil fumarate.
    Wolfram RM; Kritz H; Oguogho A; Sinzinger H
    Thromb Res; 2002 May; 106(4-5):187-90. PubMed ID: 12297124
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antiremodeling effects of iloprost and the dual-selective phosphodiesterase 3/4 inhibitor tolafentrine in chronic experimental pulmonary hypertension.
    Schermuly RT; Kreisselmeier KP; Ghofrani HA; Samidurai A; Pullamsetti S; Weissmann N; Schudt C; Ermert L; Seeger W; Grimminger F
    Circ Res; 2004 Apr; 94(8):1101-8. PubMed ID: 15031263
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pulmonary artery remodeling differs in hypoxia- and monocrotaline-induced pulmonary hypertension.
    van Suylen RJ; Smits JF; Daemen MJ
    Am J Respir Crit Care Med; 1998 May; 157(5 Pt 1):1423-8. PubMed ID: 9603118
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.